SR201
Log in to followA RESOLUTION encouraging Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in Kentucky.
Encourage Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in the Commonwealth.
Introduced: March 26, 2026
Last action: April 1, 2026
Plain-language summary
This resolution encourages Kentucky policymakers to look into and create economic development policies aimed at attracting investment and growth in the biopharmaceutical industry within the state. It does not create new laws or programs on its own, but signals the Senate's support for exploring this direction. Biopharmaceuticals involve the development of medicines and treatments derived from biological sources. Who it may affect: Kentuckians working in or seeking jobs in the life sciences and pharmaceutical industries, as well as researchers and businesses in that sector.
Open official bill text (PDF)·Report a problem with the summary
Bill Text Versions
Legislative History
Primary Sponsor
Co-sponsors (1)
Something wrong on this page? Tell us
